The proposal was outlined in its briefing documents which would be voted on by its panel of external advisers on Thursday.
(Reporting by Leroy Leo in Bengaluru; Editing by Shailesh Kuber)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
126.1 USD | +3.78% |
|
+9.14% | +27.38% |
07-15 | Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing | MT |
07-12 | China approves CSPC Pharma's RSV vaccine for clinical trials | RE |
(Reuters) - The U.S. Food and Drug Administration on Monday proposed the use the latest updated shot available for disease, similar to the annual influenza immunization campaign, as it moves to simplify the COVID-19 vaccination strategy.
The proposal was outlined in its briefing documents which would be voted on by its panel of external advisers on Thursday.
(Reporting by Leroy Leo in Bengaluru; Editing by Shailesh Kuber)
1st Jan change | Capi. | |
---|---|---|
+27.38% | 46.56B | |
+45.38% | 41.67B | |
+0.38% | 41.16B | |
+32.67% | 32.4B | |
+20.89% | 28.18B | |
-6.35% | 28.1B | |
+48.89% | 14.52B | |
+48.30% | 13.74B | |
+3.15% | 12.17B | |
-4.20% | 11.14B |